recent articles

Affordable and scanner agnostic image analysis solutions utilizing artificial intelligence for colorimetric and morphometric analysis for oncology, neuroscience and toxicological pathology SUNNYVALE, CA--(BUSINESS WIRE)—OptraSCAN, Inc....

OptraSCANTM On-Demand Digital Pathology announced today the availability of a Breast Cancer Focused Panel of Algorithmic Biomarkers (ER/PR, HER-2/neu, Ki67, P53, EGFR, AE1/AE3) through its OptraASSAYSTM and OptraCARDSTM Solutions, as part of...

OR

platinum partners

gold partners

Silver Partners

Media Partners